journal

Endocrine Pathology | Page 2

journal
https://read.qxmd.com/read/31811566/testing-for-braf-v600e-mutation-in-thyroid-nodules-with-fine-needle-aspiration-fna-read-as-suspicious-for-malignancy-bethesda-v-thy4-tir4-a-systematic-review-and-meta-analysis
#21
REVIEW
Pierpaolo Trimboli, Lorenzo Scappaticcio, Giorgio Treglia, Leo Guidobaldi, Massimo Bongiovanni, Luca Giovanella
In patients with thyroid fine-needle aspiration (FNA) report of suspicious for malignancy (SFM), both lobectomy and thyroidectomy might be considered. BRAF mutation analysis could guide towards accurate surgical therapy. The primary outcome was the reliability of BRAF (V600E) in detecting malignancy in nodules with FNA reading of SFM. The secondary outcome was to analyze its positive predictive value (PPV) and negative predictive value (NPV) considering the surgical histology as gold standard. A literature search of online databases was performed in June 2019...
March 2020: Endocrine Pathology
https://read.qxmd.com/read/31808008/prognostic-impact-of-mcpyv-and-til-subtyping-in-merkel-cell-carcinoma-evidence-from-a-large-european-cohort-of-95-patients
#22
C Ricci, A Righi, F Ambrosi, D Gibertoni, F Maletta, S Uccella, F Sessa, S Asioli, M Pellilli, R Maragliano, S La Rosa, M G Papotti, S Asioli
Merkel cell carcinoma is a rare (∼ 2000 cases/year in the USA) but aggressive neuroendocrine neoplasm of the skin. In 2008, the Merkel cell polyomavirus (MCPyV) was found to be clonally integrated in approximately 80% of Merkel cell carcinomas. The remaining 20% have large numbers of UV-associated mutations. Importantly, both the UV-induced neoantigens in virus-negative Merkel cell carcinoma and the Merkel cell polyomavirus oncogenes that are required for virus-positive tumor growth are highly immunogenic...
March 2020: Endocrine Pathology
https://read.qxmd.com/read/32103422/alternative-lengthening-of-telomeres-and-differential-expression-of-endocrine-transcription-factors-distinguish-metastatic-and-non-metastatic-insulinomas
#23
Wenzel M Hackeng, Willemien Schelhaas, Folkert H M Morsink, Charlotte M Heidsma, Susanne van Eeden, Gerlof D Valk, Menno R Vriens, Christopher M Heaphy, Els J M Nieveen van Dijkum, G Johan A Offerhaus, Koen M A Dreijerink, Lodewijk A A Brosens
Insulin-producing pancreatic neuroendocrine tumors (PanNETs)/insulinomas are generally considered to be indolent tumors with an excellent prognosis after complete resection. However, some insulinomas have a poor prognosis due to relapses and metastatic disease. Recently, studies in non-functional PanNETs indicated that behavior can be stratified according to alpha- and beta-cell differentiation, as defined by expression of the transcription factors ARX and PDX1, respectively. It is unknown whether similar mechanisms play a role in insulinomas...
February 26, 2020: Endocrine Pathology
https://read.qxmd.com/read/32062750/message-from-the-new-editor-in-chief-of-endocrine-pathology
#24
(no author information available yet)
No abstract text is available yet for this article.
February 15, 2020: Endocrine Pathology
https://read.qxmd.com/read/32016808/metastatic-anaplastic-thyroid-carcinoma-in-complete-remission-morphological-molecular-and-clinical-work-up-of-a-rare-case
#25
Adam Stenman, L Samuel Hellgren, Kenbugul Jatta, Martin Hysek, Maja Zemmler, Renske Altena, Inga-Lena Nilsson, Robert Bränström, Jan Zedenius, C Christofer Juhlin
Anaplastic thyroid carcinoma (ATC) exhibits an exceedingly poor prognosis, and the current treatment options are, for most cases, palliative by nature. Few reports of long-time survivors exist, although in these patients, tumors often were limited to the thyroid and/or regional lymph nodes. We describe a 64-year-old male who developed a rapidly growing mass in the left thyroid lobe. A fine-needle aspiration biopsy (FNAB) was consistent with ATC, and the patient underwent preoperative combined chemo- and radiotherapy followed by a hemithyroidectomy...
February 3, 2020: Endocrine Pathology
https://read.qxmd.com/read/31981075/gallbladder-mixed-neuroendocrine-non-neuroendocrine-neoplasm-minen-arising-in-intracholecystic-papillary-neoplasm-clinicopathologic-and-molecular-analysis-of-a-case-and-review-of-the-literature
#26
Amedeo Sciarra, Edoardo Missiaglia, Mounir Trimech, Emmanuel Melloul, Jean-Philippe Brouland, Christine Sempoux, Stefano La Rosa
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of the gallbladder are generally composed of adenocarcinoma and neuroendocrine carcinoma (NEC). Rare cases associated with intracholecystic papillary neoplasm (ICPN) have been reported. Although recent molecular data suggest that the different components of digestive MiNENs originate from a common precursor stem cell, this aspect has been poorly investigated in gallbladder MiNENs. We describe the clinicopathologic and molecular features of a MiNEN composed of ICPN, adenocarcinoma, and NEC...
January 24, 2020: Endocrine Pathology
https://read.qxmd.com/read/31912298/do-you-know-the-details-of-your-pax8-antibody-monoclonal-pax8-mrq-50-is-not-expressed-in-a-series-of-45-medullary-thyroid-carcinomas
#27
Hasan Gucer, Sultan Caliskan, Mehmet Kefeli, Ozgur Mete
Medullary thyroid carcinomas display cytologic and architectural features that can simulate various primary and metastatic neoplasms. PAX8 immunoexpression in neuroendocrine neoplasms yielded antibody-dependent findings. Since the data regarding the expression profile of monoclonal PAX8 (MRQ-50) antibody is limited in large series of medullary thyroid carcinomas, this study investigated the expression profile of PAX8 (MRQ-50) in a series of 45 medullary thyroid carcinomas. PAX8 (MRQ-50) expression was noted in the thyroid follicular epithelial cells surrounding the tumor and was negative in all medullary thyroid carcinomas...
January 7, 2020: Endocrine Pathology
https://read.qxmd.com/read/31898282/risk-of-malignancy-rom-of-thyroid-fna-diagnosed-as-suspicious-for-malignancy-or-malignant-an-institutional-experience-with-systematic-review-and-meta-analysis-of-literature
#28
REVIEW
Pierpaolo Trimboli, Franco Fulciniti, Gaetano Paone, Jessica Barizzi, Arnoldo Piccardo, Elisabetta Merlo, Luca Mazzucchelli, Luca Giovanella
A universal recommendation does not exist for thyroid FNA suspicious for malignancy (SFM). In this context, the guidelines have estimated a risk of malignancy (ROM) from 50 to 80% and both total thyroidectomy and lobectomy may be indicated. This study aimed to (1) retrospectively evaluate the SFM (i.e., TIR4) in a single institution to estimate their cancer prevalence at histology, and (2) systematic review the literature to obtain more robust information. The study period was 2015-2018. As a major inclusion criterion, both cytology and histology had to be performed in our institution...
January 2, 2020: Endocrine Pathology
https://read.qxmd.com/read/31828584/a-novel-expression-profile-of-cell-cycle-and-dna-repair-proteins-in-nonfunctioning-pituitary-adenomas
#29
Derya Metin-Armagan, Nil Comunoglu, Gulay Bulut, Pinar Kadioglu, Hiraku Kameda, Nurperi Gazioglu, Necmettin Tanriover, Melek Ozturk
The molecular mechanisms underlying the formation of nonfunctioning pituitary adenomas (NFAs) are largely unknown. In this study, we aimed to understand the relationship between NFAs and functional pituitary adenomas and the possible role of proteins involved in cell cycle, senescence, and DNA damage control mechanisms in the etiology of NFA. We analyzed pATM-S1981, pRb-S608, Rb, pE2F1-S364, p16, E2F1, p73, cyclin D1, and CHEK2 protein expression (in a group of 20 patients with acromegaly, 18 patients with Cushing's disease (CD), and 29 NFA patients) by immunohistochemistry and their relevant mRNA expression by qRT-PCR (in a group of 7 patients with acromegaly, 7 patients with CD, and 7 NFA patients)...
December 11, 2019: Endocrine Pathology
https://read.qxmd.com/read/31828583/predictive-factors-for-lateral-lymph-node-metastasis-and-skip-metastasis-in-papillary-thyroid-carcinoma
#30
Jia-Wei Feng, An-Cheng Qin, Jing Ye, Hua Pan, Yong Jiang, Zhen Qu
In papillary thyroid cancer (PTC) patients, cervical lymph node metastases are common, which disseminate sequentially from the central neck to the lateral neck. However, there is also a chaotic pattern of lymph node metastasis occasionally. In this study, we summarized 653 PTC patients who underwent thyroidectomy and central lymph node dissection with or without lateral lymph node dissection from two hospitals to investigate the pattern and risk factors of lateral lymph node metastasis (LLNM) and skip metastasis...
December 11, 2019: Endocrine Pathology
https://read.qxmd.com/read/31788765/napsin-a-expression-in-subtypes-of-thyroid-tumors-comparison-with-lung-adenocarcinomas
#31
Jianghua Wu, Yanhui Zhang, Tingting Ding, Runfen Cheng, Wenchen Gong, Yuhong Guo, Ye Luo, Yi Pan, Qiongli Zhai, Wei Sun, Dongmei Lin, Baocun Sun
Napsin A is widely used in the diagnosis of lung adenocarcinoma and has also been reported to be positive in cases of thyroid carcinomas. We investigated napsin A levels through immunohistochemistry on whole sections of 210 primary thyroid tumors of various subtypes and another 41 metastatic thyroid carcinomas, and compared these with 125 primary and 25 metastatic lung adenocarcinomas. The results showed that napsin A was expressed in 23.8% thyroid tumors and 30.3% papillary thyroid carcinomas. Most cases showed a focal and weak to moderate expression...
December 1, 2019: Endocrine Pathology
https://read.qxmd.com/read/31734934/loss-of-bap1-in-pheochromocytomas-and-paragangliomas-seems-unrelated-to-genetic-mutations
#32
Valeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, Vincenza Guzzardo, Chiara Menin, Lisa Elefanti, Francesca Schiavi, Maria Guido, Ambrogio Fassina
Breast cancer-associated protein 1 (BAP1) gene is a broad-spectrum tumor suppressor. Indeed, its loss of expression, due to biallelic inactivating mutations or deletions, has been described in several types of tumors including melanoma, malignant mesothelioma, renal cell carcinoma, and others. There are so far only two reports of BAP1-mutated paraganglioma, suggesting the possible involvement of this gene in paraganglioma (PGL) and pheochromocytoma (PCC) pathogenesis. We assessed BAP1 expression by immunohistochemistry (IHC) in a cohort of 56 PCC/PGL patients (and corresponding metastases, when available)...
December 2019: Endocrine Pathology
https://read.qxmd.com/read/31773482/endocrine-pathology-society-hubert-wolfe-award-for-2019-call-for-nominations
#33
(no author information available yet)
No abstract text is available yet for this article.
November 26, 2019: Endocrine Pathology
https://read.qxmd.com/read/31734935/using-a-novel-diagnostic-nomogram-to-differentiate-malignant-from-benign-parathyroid-neoplasms
#34
Angelica M Silva-Figueroa, Roland Bassett, Ioannis Christakis, Pablo Moreno, Callisia N Clarke, Naifa L Busaidy, Elizabeth G Grubbs, Jeffrey E Lee, Nancy D Perrier, Michelle D Williams
We sought to develop an immunohistochemical (IHC) tool to support the diagnosis of parathyroid carcinoma (PC) and help differentiate it from atypical parathyroid neoplasms (atypical) and benign adenomas. Distinguishing PC from benign parathyroid neoplasms can be challenging. Many cases of PC are histopathologically borderline for definitive malignancy. Recently, individual IHC biomarkers have been evaluated to aid in discrimination between parathyroid neoplasms. PC, atypical parathyroid neoplasms, and parathyroid adenomas treated at our institution from 1997 to 2014 were studied retrospectively...
November 16, 2019: Endocrine Pathology
https://read.qxmd.com/read/31705439/malignant-intrarenal-renal-pelvis-paraganglioma-with-co-occurring-sdhb-and-atrx-mutations
#35
Trent Irwin, Eric Q Konnick, Maria S Tretiakova
Paragangliomas are rare neuroendocrine tumors which originate from embryonic neural crest cells. These tumors may arise from parasympathetic or sympathetic paraganglia, may secrete catecholamines, and can occur in varied anatomic locations, with some locations being less common than others. Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas and pheochromocytomas and have been associated with germline heterozygous mutations in MAX, SDHA, SDHAF2, SDHB, SDHC, SDHD, or TMEM127...
November 8, 2019: Endocrine Pathology
https://read.qxmd.com/read/31664609/molecular-heterogeneity-of-papillary-thyroid-cancer-comparison-of-primary-tumors-and-synchronous-metastases-in-regional-lymph-nodes-by-mass-spectrometry-imaging
#36
Marta Gawin, Agata Kurczyk, Ewa Stobiecka, Katarzyna Frątczak, Joanna Polańska, Monika Pietrowska, Piotr Widłak
Intra-tumor heterogeneity results from both genetic heterogeneity of cancer (sub)clones and phenotypic plasticity of cancer cells that could be induced by different local microenvironments. Here, we used mass spectrometry imaging (MSI) to compare molecular profiles of primary tumors located in the thyroid gland and their synchronous metastases in regional lymph nodes to analyze phenotypic heterogeneity in papillary thyroid cancer. Two types of cancerous (primary tumor and metastasis) and two types of not cancerous (thyroid gland and lymph node) regions of interest (ROIs) were delineated in postoperative material from 11 patients, then the distribution of tryptic peptides (spectral components) was analyzed by MSI in all tissue regions...
October 30, 2019: Endocrine Pathology
https://read.qxmd.com/read/31605276/preoperative-diagnostic-categories-of-noninvasive-follicular-thyroid-neoplasm-with-papillary-like-nuclear-features-in-thyroid-core-needle-biopsy-and-its-impact-on-risk-of-malignancy
#37
Hee Young Na, Ji Won Woo, Jae Hoon Moon, June Young Choi, Woo-Jin Jeong, Yeo Koon Kim, Ji-Young Choe, So Yeon Park
This study was designed to evaluate the preoperative diagnostic categories of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) using thyroid core needle biopsy (CNB) and to analyze its impact on the risk of malignancy (ROM). A total of 2687 consecutive thyroid CNBs were reviewed retrospectively and classified into six diagnostic categories using a standardized reporting system similar to the Bethesda System for Reporting Thyroid Cytopathology. Diagnostic categories of CNBs were compared with the final surgical diagnoses, and the ROM in each category was calculated both before and after excluding NIFTP from malignancy...
October 12, 2019: Endocrine Pathology
https://read.qxmd.com/read/31529211/the-role-of-braf-v600e-in-reducing-aus-flus-diagnosis-in-thyroid-fine-needle-aspiration
#38
Lei Yin, Yi Tang, Shanshan Yu, Chenglong Wang, Ming Xiao, Yalan Wang, Shu Jun Liu, Lu Gao, Keli Huang, Ling Jin
BRAF V600E mutations are common in papillary thyroid carcinoma (PTC) and some de-differentiated thyroid cancers. In this study, we summarize AUS/FLUS diagnosed cases from thyroid fine needle aspirations in our center from 2015 to 2017 to explore the impact of BRAF V600E detection on the cytopathological diagnosis of PTC. BRAF V600E detection could significantly reduce the AUS/FLUS diagnosis rates from 11.59 to 8.42% when all BRAF V600E-mutated AUS/FLUS cases were diagnosed as conforming to PTC (20.01 to 19...
September 16, 2019: Endocrine Pathology
https://read.qxmd.com/read/31494787/ret-proto-oncogene-gene-mutation-is-related-to-cervical-lymph-node-metastasis-in-medullary-thyroid-carcinoma
#39
Sisi Wang, Bo Wang, Chao Xie, Daoxiong Ye
RET proto-oncogene (RET) mutations were proved to be related to the development of medullary thyroid carcinoma (MTC). We aimed to analyze the role of RET mutations in cervical lymph node metastasis in patients with MTC. Forty-nine patients with preoperatively diagnosed MTC by fine-needle aspiration cytology (FNAC) who underwent bilateral total thyroidectomy with cervical lymphadenectomy were included. Postoperative RET gene test and pathological analysis were performed with the surgical specimens; serum calcitonin (Ctn) and carcinoembryonic antigen (CEA) levels were tested pre- and postoperatively, to evaluate the association between RET mutations and cervical lymph node metastasis in MTC...
September 7, 2019: Endocrine Pathology
https://read.qxmd.com/read/31338752/systematic-review-and-meta-analysis-of-the-impact-of-noninvasive-follicular-thyroid-neoplasm-with-papillary-like-nuclear-features-niftp-on-cytological-diagnosis-and-thyroid-cancer-prevalence
#40
Darin Ruanpeng, Wisit Cheungpasitporn, Charat Thongprayoon, James V Hennessey, Rupendra T Shrestha
A re-named diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) likely impacts the prevalence of thyroid cancer and risk of malignancy in populations based on the established Bethesda System of Reporting Thyroid Cytopathology (TBSRTC). This study was done to investigate the prevalence and cytological distribution of NIFTP. PRISMA guided systematic review was done from a database search of Pubmed, EMBASE, and Medline using the search terms "non-invasive follicular thyroid neoplasm with papillary-like nuclear features", "non-invasive follicular variant of papillary carcinoma", "niftp", and "Bethesda" until November 2018...
September 2019: Endocrine Pathology
journal
journal
30473
2
3
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"